APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cognition-Enhancing Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Cognition-Enhancing Drugs Market Analysis and Forecast 2026-2032

22 December 2025192 pages

Choose your research edition.

Industry ResearchCognition-Enhancing Drugs Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Cognition-Enhancing Drugs Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Cognition-Enhancing Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cognition-Enhancing Drugs Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Cognition-Enhancing Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Cognition-Enhancing Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Cognition-Enhancing Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Cognition-Enhancing Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Cognition-Enhancing Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Cognition-Enhancing Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Cognition-Enhancing Drugs include HVMN, Cogstate, Cognition Therapeutics, Biogen Idec and Accelerated Intelligence, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Cognition-Enhancing Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Cognition-Enhancing Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Cognition-Enhancing Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cognition-Enhancing Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cognition-Enhancing Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Cognition-Enhancing Drugs sales, projected growth trends, production technology, application and end-user industry.

Cognition-Enhancing Drugs Segment by Company

HVMN

Cogstate

Cognition Therapeutics

Biogen Idec

Accelerated Intelligence

Cognition-Enhancing Drugs Segment by Type

Oral

Injection

Cognition-Enhancing Drugs Segment by Application

Retail Pharmacies

Drug Stores

Hospital Pharmacies

Cognition-Enhancing Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cognition-Enhancing Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cognition-Enhancing Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cognition-Enhancing Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Cognition-Enhancing Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Cognition-Enhancing Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cognition-Enhancing Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cognition-Enhancing Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oral Major Manufacturers Table 3. Injection Major Manufacturers Table 4. Global Cognition-Enhancing Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Retail Pharmacies Major Manufacturers Table 6. Drug Stores Major Manufacturers Table 7. Hospital Pharmacies Major Manufacturers Table 8. Cognition-Enhancing Drugs Industry Trends Table 9. Cognition-Enhancing Drugs Industry Drivers Table 10. Cognition-Enhancing Drugs Industry Opportunities and Challenges Table 11. Cognition-Enhancing Drugs Industry Restraints Table 12. Global Cognition-Enhancing Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Cognition-Enhancing Drugs Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Cognition-Enhancing Drugs Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Cognition-Enhancing Drugs Revenue Market Share by Region (2021-2026) Table 16. Global Cognition-Enhancing Drugs Revenue Market Share by Region (2027-2032) Table 17. Global Cognition-Enhancing Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k tons) Table 18. Global Cognition-Enhancing Drugs Sales by Region (2021-2026) & (k tons) Table 19. Global Cognition-Enhancing Drugs Sales by Region (2027-2032) & (k tons) Table 20. Global Cognition-Enhancing Drugs Sales Market Share by Region (2021-2026) Table 21. Global Cognition-Enhancing Drugs Sales Market Share by Region (2027-2032) Table 22. Global Cognition-Enhancing Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Cognition-Enhancing Drugs Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Cognition-Enhancing Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Cognition-Enhancing Drugs Sales Market Share by Manufacturers (2021-2026) Table 26. Global Cognition-Enhancing Drugs Sales Price (US$/ton) of Manufacturers (2021-2026) Table 27. Global Cognition-Enhancing Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Cognition-Enhancing Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Cognition-Enhancing Drugs Manufacturers, Product Type & Application Table 30. Global Cognition-Enhancing Drugs Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Cognition-Enhancing Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Cognition-Enhancing Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Cognition-Enhancing Drugs Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Cognition-Enhancing Drugs Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Cognition-Enhancing Drugs Revenue Market Share by Type (2021-2026) Table 37. Global Cognition-Enhancing Drugs Revenue Market Share by Type (2027-2032) Table 38. Global Cognition-Enhancing Drugs Sales by Type 2021 VS 2025 VS 2032 (k tons) Table 39. Global Cognition-Enhancing Drugs Sales by Type (2021-2026) & (k tons) Table 40. Global Cognition-Enhancing Drugs Sales by Type (2027-2032) & (k tons) Table 41. Global Cognition-Enhancing Drugs Sales Market Share by Type (2021-2026) Table 42. Global Cognition-Enhancing Drugs Sales Market Share by Type (2027-2032) Table 43. Global Cognition-Enhancing Drugs Price by Type (2021-2026) & (US$/ton) Table 44. Global Cognition-Enhancing Drugs Price by Type (2027-2032) & (US$/ton) Table 45. Global Cognition-Enhancing Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Cognition-Enhancing Drugs Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Cognition-Enhancing Drugs Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Cognition-Enhancing Drugs Revenue Market Share by Application (2021-2026) Table 49. Global Cognition-Enhancing Drugs Revenue Market Share by Application (2027-2032) Table 50. Global Cognition-Enhancing Drugs Sales by Application 2021 VS 2025 VS 2032 (k tons) Table 51. Global Cognition-Enhancing Drugs Sales by Application (2021-2026) & (k tons) Table 52. Global Cognition-Enhancing Drugs Sales by Application (2027-2032) & (k tons) Table 53. Global Cognition-Enhancing Drugs Sales Market Share by Application (2021-2026) Table 54. Global Cognition-Enhancing Drugs Sales Market Share by Application (2027-2032) Table 55. Global Cognition-Enhancing Drugs Price by Application (2021-2026) & (US$/ton) Table 56. Global Cognition-Enhancing Drugs Price by Application (2027-2032) & (US$/ton) Table 57. HVMN Company Information Table 58. HVMN Business Overview Table 59. HVMN Cognition-Enhancing Drugs Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 60. HVMN Cognition-Enhancing Drugs Product Portfolio Table 61. HVMN Recent Development Table 62. Cogstate Company Information Table 63. Cogstate Business Overview Table 64. Cogstate Cognition-Enhancing Drugs Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 65. Cogstate Cognition-Enhancing Drugs Product Portfolio Table 66. Cogstate Recent Development Table 67. Cognition Therapeutics Company Information Table 68. Cognition Therapeutics Business Overview Table 69. Cognition Therapeutics Cognition-Enhancing Drugs Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 70. Cognition Therapeutics Cognition-Enhancing Drugs Product Portfolio Table 71. Cognition Therapeutics Recent Development Table 72. Biogen Idec Company Information Table 73. Biogen Idec Business Overview Table 74. Biogen Idec Cognition-Enhancing Drugs Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 75. Biogen Idec Cognition-Enhancing Drugs Product Portfolio Table 76. Biogen Idec Recent Development Table 77. Accelerated Intelligence Company Information Table 78. Accelerated Intelligence Business Overview Table 79. Accelerated Intelligence Cognition-Enhancing Drugs Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 80. Accelerated Intelligence Cognition-Enhancing Drugs Product Portfolio Table 81. Accelerated Intelligence Recent Development Table 82. North America Cognition-Enhancing Drugs Revenue by Type (2021-2026) & (US$ Million) Table 83. North America Cognition-Enhancing Drugs Revenue by Type (2027-2032) & (US$ Million) Table 84. North America Cognition-Enhancing Drugs Sales by Type (2021-2026) & (k tons) Table 85. North America Cognition-Enhancing Drugs Sales by Type (2027-2032) & (k tons) Table 86. North America Cognition-Enhancing Drugs Sales Price by Type (2021-2026) & (US$/ton) Table 87. North America Cognition-Enhancing Drugs Sales Price by Type (2027-2032) & (US$/ton) Table 88. North America Cognition-Enhancing Drugs Revenue by Application (2021-2026) & (US$ Million) Table 89. North America Cognition-Enhancing Drugs Revenue by Application (2027-2032) & (US$ Million) Table 90. North America Cognition-Enhancing Drugs Sales by Application (2021-2026) & (k tons) Table 91. North America Cognition-Enhancing Drugs Sales by Application (2027-2032) & (k tons) Table 92. North America Cognition-Enhancing Drugs Sales Price by Application (2021-2026) & (US$/ton) Table 93. North America Cognition-Enhancing Drugs Sales Price by Application (2027-2032) & (US$/ton) Table 94. North America Cognition-Enhancing Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America Cognition-Enhancing Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 96. North America Cognition-Enhancing Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 97. North America Cognition-Enhancing Drugs Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 98. North America Cognition-Enhancing Drugs Sales by Country (2021-2026) & (k tons) Table 99. North America Cognition-Enhancing Drugs Sales by Country (2027-2032) & (k tons) Table 100. North America Cognition-Enhancing Drugs Sales Price by Country (2021-2026) & (US$/ton) Table 101. North America Cognition-Enhancing Drugs Sales Price by Country (2027-2032) & (US$/ton) Table 102. United States Cognition-Enhancing Drugs Revenue (2021-2032) & (US$ Million) Table 103. Canada Cognition-Enhancing Drugs Revenue (2021-2032) & (US$ Million) Table 104. Mexico Cognition-Enhancing Drugs Revenue (2021-2032) & (US$ Million) Table 105. Europe Cognition-Enhancing Drugs Revenue by Type (2021-2026) & (US$ Million) Table 106. Europe Cognition-Enhancing Drugs Revenue by Type (2027-2032) & (US$ Million) Table 107. Europe Cognition-Enhancing Drugs Sales by Type (2021-2026) & (k tons) Table 108. Europe Cognition-Enhancing Drugs Sales by Type (2027-2032) & (k tons) Table 109. Europe Cognition-Enhancing Drugs Sales Price by Type (2021-2026) & (US$/ton) Table 110. Europe Cognition-Enhancing Drugs Sales Price by Type (2027-2032) & (US$/ton) Table 111. Europe Cognition-Enhancing Drugs Revenue by Application (2021-2026) & (US$ Million) Table 112. Europe Cognition-Enhancing Drugs Revenue by Application (2027-2032) & (US$ Million) Table 113. Europe Cognition-Enhancing Drugs Sales by Application (2021-2026) & (k tons) Table 114. Europe Cognition-Enhancing Drugs Sales by Application (2027-2032) & (k tons) Table 115. Europe Cognition-Enhancing Drugs Sales Price by Application (2021-2026) & (US$/ton) Table 116. Europe Cognition-Enhancing Drugs Sales Price by Application (2027-2032) & (US$/ton) Table 117. Europe Cognition-Enhancing Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Europe Cognition-Enhancing Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 119. Europe Cognition-Enhancing Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 120. Europe Cognition-Enhancing Drugs Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 121. Europe Cognition-Enhancing Drugs Sales by Country (2021-2026) & (k tons) Table 122. Europe Cognition-Enhancing Drugs Sales by Country (2027-2032) & (k tons) Table 123. Europe Cognition-Enhancing Drugs Sales Price by Country (2021-2026) & (US$/ton) Table 124. Europe Cognition-Enhancing Drugs Sales Price by Country (2027-2032) & (US$/ton) Table 125. Germany Cognition-Enhancing Drugs Revenue (2021-2032) & (US$ Million) Table 126. France Cognition-Enhancing Drugs Revenue (2021-2032) & (US$ Million) Table 127. U.K. Cognition-Enhancing Drugs Revenue (2021-2032) & (US$ Million) Table 128. Italy Cognition-Enhancing Drugs Revenue (2021-2032) & (US$ Million) Table 129. Russia Cognition-Enhancing Drugs Revenue (2021-2032) & (US$ Million) Table 130. Spain Cognition-Enhancing Drugs Revenue (2021-2032) & (US$ Million) Table 131. Netherlands Cognition-Enhancing Drugs Revenue (2021-2032) & (US$ Million) Table 132. Switzerland Cognition-Enhancing Drugs Revenue (2021-2032) & (US$ Million) Table 133. Sweden Cognition-Enhancing Drugs Revenue (2021-2032) & (US$ Million) Table 134. Poland Cognition-Enhancing Drugs Revenue (2021-2032) & (US$ Million) Table 135. China Cognition-Enhancing Drugs Revenue by Type (2021-2026) & (US$ Million) Table 136. China Cognition-Enhancing Drugs Revenue by Type (2027-2032) & (US$ Million) Table 137. China Cognition-Enhancing Drugs Sales by Type (2021-2026) & (k tons) Table 138. China Cognition-Enhancing Drugs Sales by Type (2027-2032) & (k tons) Table 139. China Cognition-Enhancing Drugs Sales Price by Type (2021-2026) & (US$/ton) Table 140. China Cognition-Enhancing Drugs Sales Price by Type (2027-2032) & (US$/ton) Table 141. China Cognition-Enhancing Drugs Revenue by Application (2021-2026) & (US$ Million) Table 142. China Cognition-Enhancing Drugs Revenue by Application (2027-2032) & (US$ Million) Table 143. China Cognition-Enhancing Drugs Sales by Application (2021-2026) & (k tons) Table 144. China Cognition-Enhancing Drugs Sales by Application (2027-2032) & (k tons) Table 145. China Cognition-Enhancing Drugs Sales Price by Application (2021-2026) & (US$/ton) Table 146. China Cognition-Enhancing Drugs Sales Price by Application (2027-2032) & (US$/ton) Table 147. Asia Cognition-Enhancing Drugs Revenue by Type (2021-2026) & (US$ Million) Table 148. Asia Cognition-Enhancing Drugs Revenue by Type (2027-2032) & (US$ Million) Table 149. Asia Cognition-Enhancing Drugs Sales by Type (2021-2026) & (k tons) Table 150. Asia Cognition-Enhancing Drugs Sales by Type (2027-2032) & (k tons) Table 151. Asia Cognition-Enhancing Drugs Sales Price by Type (2021-2026) & (US$/ton) Table 152. Asia Cognition-Enhancing Drugs Sales Price by Type (2027-2032) & (US$/ton) Table 153. Asia Cognition-Enhancing Drugs Revenue by Application (2021-2026) & (US$ Million) Table 154. Asia Cognition-Enhancing Drugs Revenue by Application (2027-2032) & (US$ Million) Table 155. Asia Cognition-Enhancing Drugs Sales by Application (2021-2026) & (k tons) Table 156. Asia Cognition-Enhancing Drugs Sales by Application (2027-2032) & (k tons) Table 157. Asia Cognition-Enhancing Drugs Sales Price by Application (2021-2026) & (US$/ton) Table 158. Asia Cognition-Enhancing Drugs Sales Price by Application (2027-2032) & (US$/ton) Table 159. Asia Cognition-Enhancing Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. Asia Cognition-Enhancing Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 161. Asia Cognition-Enhancing Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 162. Asia Cognition-Enhancing Drugs Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 163. Asia Cognition-Enhancing Drugs Sales by Country (2021-2026) & (k tons) Table 164. Asia Cognition-Enhancing Drugs Sales by Country (2027-2032) & (k tons) Table 165. Asia Cognition-Enhancing Drugs Sales Price by Country (2021-2026) & (US$/ton) Table 166. Asia Cognition-Enhancing Drugs Sales Price by Country (2027-2032) & (US$/ton) Table 167. Japan Cognition-Enhancing Drugs Revenue (2021-2032) & (US$ Million) Table 168. South Korea Cognition-Enhancing Drugs Revenue (2021-2032) & (US$ Million) Table 169. India Cognition-Enhancing Drugs Revenue (2021-2032) & (US$ Million) Table 170. Australia Cognition-Enhancing Drugs Revenue (2021-2032) & (US$ Million) Table 171. Taiwan Cognition-Enhancing Drugs Revenue (2021-2032) & (US$ Million) Table 172. Southeast Asia Cognition-Enhancing Drugs Revenue (2021-2032) & (US$ Million) Table 173. SAMEA Cognition-Enhancing Drugs Revenue by Type (2021-2026) & (US$ Million) Table 174. SAMEA Cognition-Enhancing Drugs Revenue by Type (2027-2032) & (US$ Million) Table 175. SAMEA Cognition-Enhancing Drugs Sales by Type (2021-2026) & (k tons) Table 176. SAMEA Cognition-Enhancing Drugs Sales by Type (2027-2032) & (k tons) Table 177. SAMEA Cognition-Enhancing Drugs Sales Price by Type (2021-2026) & (US$/ton) Table 178. SAMEA Cognition-Enhancing Drugs Sales Price by Type (2027-2032) & (US$/ton) Table 179. SAMEA Cognition-Enhancing Drugs Revenue by Application (2021-2026) & (US$ Million) Table 180. SAMEA Cognition-Enhancing Drugs Revenue by Application (2027-2032) & (US$ Million) Table 181. SAMEA Cognition-Enhancing Drugs Sales by Application (2021-2026) & (k tons) Table 182. SAMEA Cognition-Enhancing Drugs Sales by Application (2027-2032) & (k tons) Table 183. SAMEA Cognition-Enhancing Drugs Sales Price by Application (2021-2026) & (US$/ton) Table 184. SAMEA Cognition-Enhancing Drugs Sales Price by Application (2027-2032) & (US$/ton) Table 185. SAMEA Cognition-Enhancing Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. SAMEA Cognition-Enhancing Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 187. SAMEA Cognition-Enhancing Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 188. SAMEA Cognition-Enhancing Drugs Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 189. SAMEA Cognition-Enhancing Drugs Sales by Country (2021-2026) & (k tons) Table 190. SAMEA Cognition-Enhancing Drugs Sales by Country (2027-2032) & (k tons) Table 191. SAMEA Cognition-Enhancing Drugs Sales Price by Country (2021-2026) & (US$/ton) Table 192. SAMEA Cognition-Enhancing Drugs Sales Price by Country (2027-2032) & (US$/ton) Table 193. Brazil Cognition-Enhancing Drugs Revenue (2021-2032) & (US$ Million) Table 194. Argentina Cognition-Enhancing Drugs Revenue (2021-2032) & (US$ Million) Table 195. Chile Cognition-Enhancing Drugs Revenue (2021-2032) & (US$ Million) Table 196. Colombia Cognition-Enhancing Drugs Revenue (2021-2032) & (US$ Million) Table 197. Peru Cognition-Enhancing Drugs Revenue (2021-2032) & (US$ Million) Table 198. Saudi Arabia Cognition-Enhancing Drugs Revenue (2021-2032) & (US$ Million) Table 199. Israel Cognition-Enhancing Drugs Revenue (2021-2032) & (US$ Million) Table 200. UAE Cognition-Enhancing Drugs Revenue (2021-2032) & (US$ Million) Table 201. Turkey Cognition-Enhancing Drugs Revenue (2021-2032) & (US$ Million) Table 202. Iran Cognition-Enhancing Drugs Revenue (2021-2032) & (US$ Million) Table 203. Egypt Cognition-Enhancing Drugs Revenue (2021-2032) & (US$ Million) Table 204. Key Raw Materials Table 205. Raw Materials Key Suppliers Table 206. Cognition-Enhancing Drugs Distributors List Table 207. Cognition-Enhancing Drugs Customers List Table 208. Research Programs/Design for This Report Table 209. Authors List of This Report Table 210. Secondary Sources Table 211. Primary Sources List of Figures Figure 1. Cognition-Enhancing Drugs Image Figure 2. Global Cognition-Enhancing Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cognition-Enhancing Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oral Image Figure 5. Injection Image Figure 6. Global Cognition-Enhancing Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Cognition-Enhancing Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 8. Retail Pharmacies Image Figure 9. Drug Stores Image Figure 10. Hospital Pharmacies Image Figure 11. Global Cognition-Enhancing Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Cognition-Enhancing Drugs Revenue (2021-2032) & (US$ Million) Figure 13. Global Cognition-Enhancing Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Cognition-Enhancing Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Cognition-Enhancing Drugs Revenue Market Share by Region (2021-2032) Figure 16. Global Cognition-Enhancing Drugs Sales (2021-2032) & (k tons) Figure 17. Global Cognition-Enhancing Drugs Sales by Region: 2021 VS 2025 VS 2032 (k tons) Figure 18. Global Cognition-Enhancing Drugs Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Cognition-Enhancing Drugs Sales YoY (2021-2032) & (k tons) Figure 20. Europe Cognition-Enhancing Drugs Sales YoY (2021-2032) & (k tons) Figure 21. China Cognition-Enhancing Drugs Sales YoY (2021-2032) & (k tons) Figure 22. Asia (Excluding China) Cognition-Enhancing Drugs Sales YoY (2021-2032) & (k tons) Figure 23. South America, Middle East and Africa Cognition-Enhancing Drugs Sales YoY (2021-2032) & (k tons) Figure 24. Global Cognition-Enhancing Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Cognition-Enhancing Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Cognition-Enhancing Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Cognition-Enhancing Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Cognition-Enhancing Drugs Revenue Market Share by Type (2021-2032) Figure 30. Global Cognition-Enhancing Drugs Sales by Type (2021 VS 2025 VS 2032) & (k tons) Figure 31. Global Cognition-Enhancing Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Cognition-Enhancing Drugs Sales Market Share by Type (2021-2032) Figure 33. Global Cognition-Enhancing Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Cognition-Enhancing Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Cognition-Enhancing Drugs Revenue Market Share by Application (2021-2032) Figure 36. Global Cognition-Enhancing Drugs Sales by Application (2021 VS 2025 VS 2032) & (k tons) Figure 37. Global Cognition-Enhancing Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Cognition-Enhancing Drugs Sales Market Share by Application (2021-2032) Figure 39. North America Cognition-Enhancing Drugs Revenue Share by Type (2021-2032) Figure 40. North America Cognition-Enhancing Drugs Sales Share by Type (2021-2032) Figure 41. North America Cognition-Enhancing Drugs Revenue Share by Application (2021-2032) Figure 42. North America Cognition-Enhancing Drugs Sales Share by Application (2021-2032) Figure 43. North America Cognition-Enhancing Drugs Revenue Share by Country (2021-2032) Figure 44. North America Cognition-Enhancing Drugs Sales Share by Country (2021-2032) Figure 45. Europe Cognition-Enhancing Drugs Revenue Share by Type (2021-2032) Figure 46. Europe Cognition-Enhancing Drugs Sales Share by Type (2021-2032) Figure 47. Europe Cognition-Enhancing Drugs Revenue Share by Application (2021-2032) Figure 48. Europe Cognition-Enhancing Drugs Sales Share by Application (2021-2032) Figure 49. Europe Cognition-Enhancing Drugs Revenue Share by Country (2021-2032) Figure 50. Europe Cognition-Enhancing Drugs Sales Share by Country (2021-2032) Figure 51. China Cognition-Enhancing Drugs Revenue Share by Type (2021-2032) Figure 52. China Cognition-Enhancing Drugs Sales Share by Type (2021-2032) Figure 53. China Cognition-Enhancing Drugs Revenue Share by Application (2021-2032) Figure 54. China Cognition-Enhancing Drugs Sales Share by Application (2021-2032) Figure 55. Asia Cognition-Enhancing Drugs Revenue Share by Type (2021-2032) Figure 56. Asia Cognition-Enhancing Drugs Sales Share by Type (2021-2032) Figure 57. Asia Cognition-Enhancing Drugs Revenue Share by Application (2021-2032) Figure 58. Asia Cognition-Enhancing Drugs Sales Share by Application (2021-2032) Figure 59. Asia Cognition-Enhancing Drugs Revenue Share by Country (2021-2032) Figure 60. Asia Cognition-Enhancing Drugs Sales Share by Country (2021-2032) Figure 61. SAMEA Cognition-Enhancing Drugs Revenue Share by Type (2021-2032) Figure 62. SAMEA Cognition-Enhancing Drugs Sales Share by Type (2021-2032) Figure 63. SAMEA Cognition-Enhancing Drugs Revenue Share by Application (2021-2032) Figure 64. SAMEA Cognition-Enhancing Drugs Sales Share by Application (2021-2032) Figure 65. SAMEA Cognition-Enhancing Drugs Revenue Share by Country (2021-2032) Figure 66. SAMEA Cognition-Enhancing Drugs Sales Share by Country (2021-2032) Figure 67. Cognition-Enhancing Drugs Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Cognition-Enhancing Drugs Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injection
Applications
  • Retail Pharmacies
  • Drug Stores
  • Hospital Pharmacies
Companies covered
  • HVMN
  • Cogstate
  • Cognition Therapeutics
  • Biogen Idec
  • Accelerated Intelligence

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Cognition-Enhancing Drugs Market by Type
  3. 1.2.1 Global Cognition-Enhancing Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oral
  5. 1.2.3 Injection
  6. 1.3 Cognition-Enhancing Drugs Market by Application
  7. 1.3.1 Global Cognition-Enhancing Drugs Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Retail Pharmacies
  9. 1.3.3 Drug Stores
  10. 1.3.4 Hospital Pharmacies
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Cognition-Enhancing Drugs Market Dynamics
  1. 2.1 Cognition-Enhancing Drugs Industry Trends
  2. 2.2 Cognition-Enhancing Drugs Industry Drivers
  3. 2.3 Cognition-Enhancing Drugs Industry Opportunities and Challenges
  4. 2.4 Cognition-Enhancing Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Cognition-Enhancing Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Cognition-Enhancing Drugs Revenue by Region
  3. 3.2.1 Global Cognition-Enhancing Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Cognition-Enhancing Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Cognition-Enhancing Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Cognition-Enhancing Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Cognition-Enhancing Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Cognition-Enhancing Drugs Sales by Region
  9. 3.4.1 Global Cognition-Enhancing Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Cognition-Enhancing Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Cognition-Enhancing Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Cognition-Enhancing Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Cognition-Enhancing Drugs Revenue by Manufacturers
  2. 4.1.1 Global Cognition-Enhancing Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Cognition-Enhancing Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Cognition-Enhancing Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Cognition-Enhancing Drugs Sales by Manufacturers
  6. 4.2.1 Global Cognition-Enhancing Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Cognition-Enhancing Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Cognition-Enhancing Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Cognition-Enhancing Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Cognition-Enhancing Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Cognition-Enhancing Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Cognition-Enhancing Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Cognition-Enhancing Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Cognition-Enhancing Drugs Market CR5 and HHI
  16. 4.8.2 2025 Cognition-Enhancing Drugs Tier 1, Tier 2, and Tier 3
5 Cognition-Enhancing Drugs Market by Type
  1. 5.1 Global Cognition-Enhancing Drugs Revenue by Type
  2. 5.1.1 Global Cognition-Enhancing Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Cognition-Enhancing Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Cognition-Enhancing Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Cognition-Enhancing Drugs Sales by Type
  6. 5.2.1 Global Cognition-Enhancing Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Cognition-Enhancing Drugs Sales by Type (2021-2032) & (k tons)
  8. 5.2.3 Global Cognition-Enhancing Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Cognition-Enhancing Drugs Price by Type
6 Cognition-Enhancing Drugs Market by Application
  1. 6.1 Global Cognition-Enhancing Drugs Revenue by Application
  2. 6.1.1 Global Cognition-Enhancing Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Cognition-Enhancing Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Cognition-Enhancing Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Cognition-Enhancing Drugs Sales by Application
  6. 6.2.1 Global Cognition-Enhancing Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Cognition-Enhancing Drugs Sales by Application (2021-2032) & (k tons)
  8. 6.2.3 Global Cognition-Enhancing Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Cognition-Enhancing Drugs Price by Application
7 Company Profiles
  1. 7.1 HVMN
  2. 7.1.1 HVMN Company Information
  3. 7.1.2 HVMN Business Overview
  4. 7.1.3 HVMN Cognition-Enhancing Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 HVMN Cognition-Enhancing Drugs Product Portfolio
  6. 7.1.5 HVMN Recent Developments
  7. 7.2 Cogstate
  8. 7.2.1 Cogstate Company Information
  9. 7.2.2 Cogstate Business Overview
  10. 7.2.3 Cogstate Cognition-Enhancing Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Cogstate Cognition-Enhancing Drugs Product Portfolio
  12. 7.2.5 Cogstate Recent Developments
  13. 7.3 Cognition Therapeutics
  14. 7.3.1 Cognition Therapeutics Company Information
  15. 7.3.2 Cognition Therapeutics Business Overview
  16. 7.3.3 Cognition Therapeutics Cognition-Enhancing Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Cognition Therapeutics Cognition-Enhancing Drugs Product Portfolio
  18. 7.3.5 Cognition Therapeutics Recent Developments
  19. 7.4 Biogen Idec
  20. 7.4.1 Biogen Idec Company Information
  21. 7.4.2 Biogen Idec Business Overview
  22. 7.4.3 Biogen Idec Cognition-Enhancing Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Biogen Idec Cognition-Enhancing Drugs Product Portfolio
  24. 7.4.5 Biogen Idec Recent Developments
  25. 7.5 Accelerated Intelligence
  26. 7.5.1 Accelerated Intelligence Company Information
  27. 7.5.2 Accelerated Intelligence Business Overview
  28. 7.5.3 Accelerated Intelligence Cognition-Enhancing Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Accelerated Intelligence Cognition-Enhancing Drugs Product Portfolio
  30. 7.5.5 Accelerated Intelligence Recent Developments
8 North America
  1. 8.1 North America Cognition-Enhancing Drugs Market Size by Type
  2. 8.1.1 North America Cognition-Enhancing Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Cognition-Enhancing Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Cognition-Enhancing Drugs Price by Type (2021-2032)
  5. 8.2 North America Cognition-Enhancing Drugs Market Size by Application
  6. 8.2.1 North America Cognition-Enhancing Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Cognition-Enhancing Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Cognition-Enhancing Drugs Price by Application (2021-2032)
  9. 8.3 North America Cognition-Enhancing Drugs Market Size by Country
  10. 8.3.1 North America Cognition-Enhancing Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Cognition-Enhancing Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Cognition-Enhancing Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Cognition-Enhancing Drugs Market Size by Type
  2. 9.1.1 Europe Cognition-Enhancing Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Cognition-Enhancing Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Cognition-Enhancing Drugs Price by Type (2021-2032)
  5. 9.2 Europe Cognition-Enhancing Drugs Market Size by Application
  6. 9.2.1 Europe Cognition-Enhancing Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Cognition-Enhancing Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Cognition-Enhancing Drugs Price by Application (2021-2032)
  9. 9.3 Europe Cognition-Enhancing Drugs Market Size by Country
  10. 9.3.1 Europe Cognition-Enhancing Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Cognition-Enhancing Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Cognition-Enhancing Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Cognition-Enhancing Drugs Market Size by Type
  2. 10.1.1 China Cognition-Enhancing Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Cognition-Enhancing Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Cognition-Enhancing Drugs Price by Type (2021-2032)
  5. 10.2 China Cognition-Enhancing Drugs Market Size by Application
  6. 10.2.1 China Cognition-Enhancing Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Cognition-Enhancing Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Cognition-Enhancing Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Cognition-Enhancing Drugs Market Size by Type
  2. 11.1.1 Asia Cognition-Enhancing Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Cognition-Enhancing Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Cognition-Enhancing Drugs Price by Type (2021-2032)
  5. 11.2 Asia Cognition-Enhancing Drugs Market Size by Application
  6. 11.2.1 Asia Cognition-Enhancing Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Cognition-Enhancing Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Cognition-Enhancing Drugs Price by Application (2021-2032)
  9. 11.3 Asia Cognition-Enhancing Drugs Market Size by Country
  10. 11.3.1 Asia Cognition-Enhancing Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Cognition-Enhancing Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Cognition-Enhancing Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Cognition-Enhancing Drugs Market Size by Type
  2. 12.1.1 SAMEA Cognition-Enhancing Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Cognition-Enhancing Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Cognition-Enhancing Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Cognition-Enhancing Drugs Market Size by Application
  6. 12.2.1 SAMEA Cognition-Enhancing Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Cognition-Enhancing Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Cognition-Enhancing Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Cognition-Enhancing Drugs Market Size by Country
  10. 12.3.1 SAMEA Cognition-Enhancing Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Cognition-Enhancing Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Cognition-Enhancing Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Cognition-Enhancing Drugs Value Chain Analysis
  2. 13.1.1 Cognition-Enhancing Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Cognition-Enhancing Drugs Production Mode & Process
  6. 13.2 Cognition-Enhancing Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Cognition-Enhancing Drugs Distributors
  9. 13.2.3 Cognition-Enhancing Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst